Journal Title：Cytotherapy

The journal brings readers the latest developments in the fast moving field of cellular therapy in man. This includes cell therapy for cancer, immune disorders, inherited diseases, tissue repair and regenerative medicine. The journal covers the science, translational development and treatment with variety of cell types including hematopoietic stem cells, immune cells (dendritic cells, NK, cells, T cells, antigen presenting cells) mesenchymal stromal cells, adipose cells, nerve, muscle, vascular and endothelial cells, and induced pluripotential stem cells. We also welcome manuscripts on subcellular derivatives such as exosomes. A specific focus is on translational research that brings cell therapy to the clinic. Cytotherapy publishes original papers, reviews, position papers editorials, commentaries and letters to the editor. We welcome "Protocols in Cytotherapy" bringing standard operating procedure for production specific cell types for clinical use within the reach of the readership.

該期刊為讀者帶來快速發(fā)展的人類細(xì)胞治療領(lǐng)域的最新進(jìn)展。這包括癌癥、免疫疾病、遺傳疾病、組織修復(fù)和再生醫(yī)學(xué)的細(xì)胞治療。該期刊涵蓋各種細(xì)胞類型的科學(xué)、轉(zhuǎn)化發(fā)展和治療，包括造血干細(xì)胞、免疫細(xì)胞（樹突狀細(xì)胞、NK 細(xì)胞、T 細(xì)胞、抗原呈遞細(xì)胞）、間充質(zhì)基質(zhì)細(xì)胞、脂肪細(xì)胞、神經(jīng)、肌肉、血管和內(nèi)皮細(xì)胞以及誘導(dǎo)性多能干細(xì)胞。我們也歡迎有關(guān)亞細(xì)胞衍生物（如外泌體）的手稿。特別關(guān)注將細(xì)胞療法帶入臨床的轉(zhuǎn)化研究。Cytotherapy 發(fā)表原創(chuàng)論文、評(píng)論、立場(chǎng)文件社論、評(píng)論和致編輯的信。我們歡迎“細(xì)胞治療協(xié)議”，為讀者提供用于臨床生產(chǎn)特定細(xì)胞類型的標(biāo)準(zhǔn)操作程序。

Cytotherapy創(chuàng)刊于1999年，由Elsevier Inc.出版商出版，收稿方向涵蓋醫(yī)學(xué) - 生物工程與應(yīng)用微生物全領(lǐng)域，此刊是中等級(jí)別的SCI期刊，所以過審相對(duì)來講不是特別難，但是該刊專業(yè)認(rèn)可度不錯(cuò)，仍然是一本值得選擇的SCI期刊 。平均審稿速度 偏慢,4-8周 ，影響因子指數(shù)3.7，該期刊近期沒有被列入國(guó)際期刊預(yù)警名單，廣大學(xué)者值得一試。